These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6754320)
1. Pharmacokinetic considerations in toxicity testing. Jollow DJ; Roberts S; Price V; Longacre S; Smith C Drug Metab Rev; 1982; 13(6):983-1007. PubMed ID: 6754320 [No Abstract] [Full Text] [Related]
2. Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletion. Levy G; Galinsky RE; Lin JH Drug Metab Rev; 1982; 13(6):1009-20. PubMed ID: 6754315 [No Abstract] [Full Text] [Related]
3. Pharmacologic considerations in the design of toxicology experiments. Darby TD Clin Toxicol; 1978 Feb; 12(2):229-38. PubMed ID: 648118 [TBL] [Abstract][Full Text] [Related]
4. Application of pharmacokinetic principles in the extrapolation of animal data to humans. Gillette JR Clin Toxicol; 1976; 9(5):709-22. PubMed ID: 1000904 [No Abstract] [Full Text] [Related]
5. Biochemical basis for dose response relationships in reactive metabolite toxicity. Jollow DJ; Roberts S; Price V; Smith C Adv Exp Med Biol; 1981; 136 Pt A():99-113. PubMed ID: 7344497 [No Abstract] [Full Text] [Related]
6. Pharmacokinetics in chronic animal toxicity studies. Yacobi A; Kamath BL; Lai CM Drug Metab Rev; 1982; 13(6):1021-51. PubMed ID: 6754316 [No Abstract] [Full Text] [Related]
7. The effect of intercellular distribution of drug-metabolizing enzymes on the kinetics of stable metabolite formation and elimination by liver: first-pass effects. Pang KS Drug Metab Rev; 1983; 14(1):61-76. PubMed ID: 6839942 [No Abstract] [Full Text] [Related]
8. Nonlinear pharmacokinetics relative to toxicity and use of toxicological data. Ramsey JC Drug Metab Rev; 1982; 13(5):779-97. PubMed ID: 6754308 [No Abstract] [Full Text] [Related]
9. [Pharmacokinetic and metabolic studies in the development of drugs]. Vereczkey L Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191 [TBL] [Abstract][Full Text] [Related]
10. Conjugation-deconjugation reactions in drug metabolism and toxicity. Kauffman FC Fed Proc; 1987 May; 46(7):2434-45. PubMed ID: 3552738 [No Abstract] [Full Text] [Related]
11. Drug metabolism and actions in the aged. Garattini S Drug Nutr Interact; 1985; 4(1-2):87-97. PubMed ID: 2866941 [No Abstract] [Full Text] [Related]
12. [Pharmacology of the elderly]. Guillet P; Piette F Rev Prat; 1986 Feb; 36(11):581-92. PubMed ID: 3961396 [No Abstract] [Full Text] [Related]
13. Chemical nature of reactive intermediates as determinant of toxicologic responses. Mitchell JR; Hughes H; Lauterburg BH; Smith CV Drug Metab Rev; 1982; 13(4):539-53. PubMed ID: 6751750 [No Abstract] [Full Text] [Related]
14. Pharmacokinetics and toxicity testing. Clark B; Smith DA Crit Rev Toxicol; 1984; 12(4):343-85. PubMed ID: 6378530 [TBL] [Abstract][Full Text] [Related]
15. A discussion of drug metabolism and actions in the aged. Blumberg JB Drug Nutr Interact; 1985; 4(1-2):99-106. PubMed ID: 4075986 [No Abstract] [Full Text] [Related]
16. Some selected studies on hepatic microsomal drug-metabolizing enzymes--environment interactions. Fouts JR Drug Metab Dispos; 1973; 1(1):380-5. PubMed ID: 4149408 [No Abstract] [Full Text] [Related]
18. Induction of drug metabolism. VII. Differences in P-420 hemoproteins from untreated and 3-methylcholanthrene-treated rats. Shoeman DW; Vane FM; Mannering GJ Mol Pharmacol; 1973 May; 9(3):373-82. PubMed ID: 4710137 [No Abstract] [Full Text] [Related]
19. [Circadian rhythms in metabolism and susceptibility of drugs (author's transl)]. Kato R; Muraki T Tanpakushitsu Kakusan Koso; 1982 Jan; 27(2):158-69. PubMed ID: 7041179 [No Abstract] [Full Text] [Related]
20. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. II. Bachmann KA; Jahn D; Yang C; Schwartz J Xenobiotica; 1988 Feb; 18(2):161-7. PubMed ID: 3131970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]